JPH0723302B2 - 点眼液の光安定化法及びその安定化した点眼液 - Google Patents

点眼液の光安定化法及びその安定化した点眼液

Info

Publication number
JPH0723302B2
JPH0723302B2 JP2-510431A JP51043190A JPH0723302B2 JP H0723302 B2 JPH0723302 B2 JP H0723302B2 JP 51043190 A JP51043190 A JP 51043190A JP H0723302 B2 JPH0723302 B2 JP H0723302B2
Authority
JP
Japan
Prior art keywords
eye drops
boric acid
light
drug
borax
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2-510431A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0723302B1 (enExample
JPWO1991001718A1 (ja
Inventor
隆和 森田
四郎 三田
洋一 河嶋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Santen Pharmaceutical Co Ltd
Original Assignee
Eisai Co Ltd
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd, Santen Pharmaceutical Co Ltd filed Critical Eisai Co Ltd
Priority to JP2-510431A priority Critical patent/JPH0723302B2/ja
Publication of JPWO1991001718A1 publication Critical patent/JPWO1991001718A1/ja
Publication of JPH0723302B1 publication Critical patent/JPH0723302B1/ja
Publication of JPH0723302B2 publication Critical patent/JPH0723302B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/22—Boron compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP2-510431A 1989-08-03 1990-07-26 点眼液の光安定化法及びその安定化した点眼液 Expired - Lifetime JPH0723302B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2-510431A JPH0723302B2 (ja) 1989-08-03 1990-07-26 点眼液の光安定化法及びその安定化した点眼液

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP1-201872 1989-08-03
JP20187289 1989-08-03
JP2-510431A JPH0723302B2 (ja) 1989-08-03 1990-07-26 点眼液の光安定化法及びその安定化した点眼液

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP8250785A Division JP2929274B2 (ja) 1996-08-15 1996-08-15 点眼液の光安定化方法

Publications (3)

Publication Number Publication Date
JPWO1991001718A1 JPWO1991001718A1 (ja) 1991-07-04
JPH0723302B1 JPH0723302B1 (enExample) 1995-03-15
JPH0723302B2 true JPH0723302B2 (ja) 1995-03-15

Family

ID=16448274

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2-510431A Expired - Lifetime JPH0723302B2 (ja) 1989-08-03 1990-07-26 点眼液の光安定化法及びその安定化した点眼液

Country Status (9)

Country Link
EP (1) EP0436726B1 (enExample)
JP (1) JPH0723302B2 (enExample)
KR (1) KR930005321B1 (enExample)
AT (1) ATE96022T1 (enExample)
CA (1) CA2037057C (enExample)
DE (2) DE69004066T2 (enExample)
DK (1) DK0436726T3 (enExample)
ES (1) ES2038580T3 (enExample)
WO (1) WO1991001718A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2132826C (en) * 1992-05-06 1999-01-05 Masood Chowhan Use of borate-polyol complexes in ophthalmic compositions
US5505953A (en) * 1992-05-06 1996-04-09 Alcon Laboratories, Inc. Use of borate-polyol complexes in ophthalmic compositions
WO1994005314A1 (en) * 1992-09-08 1994-03-17 Centocor, Inc. Peptide inhibitors of leukocyte adhesion
ES2169724T3 (es) * 1992-10-02 2002-07-16 Alberta Res Council Propiedades antiinflamatorias, tolerogenicas e inmunoestimulantes de peptidos que enlazan carbohidratos.
US5453272A (en) * 1992-10-02 1995-09-26 Alberta Research Council Lectin derived carbohydrate binding-peptide
EP0759756A1 (en) * 1994-05-18 1997-03-05 Senju Pharmaceutical Co., Ltd. Pharmaceutical composition for treating glaucoma containing terazosin
DE69628303T2 (de) * 1995-08-04 2004-04-29 Abbott Japan Co., Ltd. Photostabile wässrige benzylalkoholderivate enthaltende lösung
AU2001256714A1 (en) 2000-05-15 2001-11-26 Kissei Pharmaceutical Co. Ltd. Water-based liquid preparation
JP4844706B2 (ja) * 2001-03-12 2011-12-28 ライオン株式会社 眼科用組成物
TW200305424A (en) 2002-01-29 2003-11-01 Santen Pharmaceutical Co Ltd Glaucoma-treating agent comprising bunazosin and prostaglandin
US8569367B2 (en) * 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
US8168206B1 (en) 2005-10-06 2012-05-01 Allergan, Inc. Animal protein-free pharmaceutical compositions
TW201109325A (en) * 2009-07-30 2011-03-16 Wakamoto Pharma Co Ltd Aqueous composition for eye drops
JP5648414B2 (ja) * 2009-10-21 2015-01-07 大正製薬株式会社 眼科用剤
US8957048B2 (en) 2011-10-06 2015-02-17 Allergan, Inc. Compositions for the treatment of dry eye
EP4403220A3 (en) 2011-12-07 2024-10-23 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
JP6571391B2 (ja) * 2014-05-30 2019-09-04 千寿製薬株式会社 水性製剤
AU2015353701B2 (en) 2014-11-25 2021-03-25 Allergan, Inc. Stabilized omega-3 ophthalmic compositions
WO2020197816A1 (en) * 2019-03-26 2020-10-01 Martin Uram Anesthetic composition and method of anesthetizing the eye

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2445366A (en) * 1945-10-02 1948-07-20 Us Sec War Ophthalmic compositions
US3966905A (en) * 1973-05-29 1976-06-29 Barnes-Hind Pharmaceuticals, Inc. Stabilized catechol amine solutions
FR2231377B1 (enExample) * 1973-05-29 1977-11-04 Barnes Hind Pharm Inc
JPS5762218A (en) * 1980-10-01 1982-04-15 Lion Corp Ophthalmic solution
JPS57106612A (en) * 1980-12-23 1982-07-02 Lion Corp Eye drop
JPS59130900A (ja) * 1983-01-17 1984-07-27 Zeria Shinyaku Kogyo Kk フルオロメトロン水性製剤の製造法
AU573321B2 (en) * 1984-03-14 1988-06-02 Jerome Corbiere Process for solubilizing active principles and pharmaceuticalcompositions thus obtained
JPS62149614A (ja) * 1985-12-24 1987-07-03 Lion Corp 点眼用製剤
JPS62277323A (ja) * 1986-02-19 1987-12-02 Sankyo Co Ltd フマル酸ケトチフエン含有点眼液の製法
DE3612538A1 (de) * 1986-04-14 1987-10-15 Dispersa Ag Stabilisierung von quecksilberhaltigen konservierungsmitteln in augentropfen
FR2598081B1 (fr) * 1986-04-30 1990-02-02 Chauvin Blache Lab Procede de preparation d'une solution pharmaceutique aqueuse d'un principe actif constitue par un acide organique
JPS6391331A (ja) * 1986-10-03 1988-04-22 Senjiyu Seiyaku Kk 眼科用水性組成物
JPH0696533B2 (ja) * 1987-01-14 1994-11-30 北陸製薬株式会社 キノロンカルボン酸の水性組成物
JPH0825874B2 (ja) * 1987-05-28 1996-03-13 ロ−ト製薬株式会社 グアイアズレンスルホン酸ナトリウム配合の安定な点眼剤の製造法
JP2563336B2 (ja) * 1987-06-01 1996-12-11 エーザイ株式会社 角膜透過促進点眼剤
JP2671353B2 (ja) * 1988-03-02 1997-10-29 大正製薬株式会社 点眼剤
JP2822058B2 (ja) * 1989-05-29 1998-11-05 ゼリア新薬工業株式会社 安定な点眼剤
JPH0478614A (ja) * 1990-05-02 1992-03-12 Nippondenso Co Ltd 冷凍サイクル
JPH0510328A (ja) * 1991-07-03 1993-01-19 Nippon Seiko Kk 高速遠心分離機

Also Published As

Publication number Publication date
CA2037057C (en) 1995-03-21
DK0436726T3 (da) 1993-12-27
DE436726T1 (de) 1992-02-06
ES2038580T3 (es) 1994-10-16
KR930005321B1 (ko) 1993-06-17
ATE96022T1 (de) 1993-11-15
JPH0723302B1 (enExample) 1995-03-15
DE69004066T2 (de) 1994-02-17
EP0436726A1 (en) 1991-07-17
WO1991001718A1 (en) 1991-02-21
ES2038580T1 (es) 1993-08-01
EP0436726B1 (en) 1993-10-20
EP0436726A4 (en) 1991-10-16
DE69004066D1 (de) 1993-11-25

Similar Documents

Publication Publication Date Title
JPH0723302B2 (ja) 点眼液の光安定化法及びその安定化した点眼液
JPWO1991001718A1 (ja) 光安定化塩酸ブナゾシン点眼液
US4857312A (en) Dihydropyridine spray, process for its preparation and its pharmaceutical use
RU2527680C2 (ru) Стабилизированная композиция, содержащая по меньшей мере одно адренергическое соединение
ES2224651T3 (es) Metodo para estabilizar composiciones farmaceuticas por medio del uso especial de un antioxidante.
KR0185377B1 (ko) 정신작용성 약물의 안정화된 용액
EP1386606B1 (en) Stable high-concentration injection containing pyrazolone derivative
CA2011063C (en) Nicardipine pharmaceutical composition for parenteral administration
JP2021519817A (ja) 液体薬学的製剤
US5290774A (en) Photostabilizing method for ophthalmic solutions and the resulting ophthalmic solutions therefrom
JP2929274B2 (ja) 点眼液の光安定化方法
KR100188318B1 (ko) 안정화된 주사제 및 주사제의 안정화법
JPS63215641A (ja) ゼラチン皮膜組成物
KR20050025137A (ko) 수성액제 및 광안정화된 수성액제
DE2422760A1 (de) Stabilisierte catecholaminloesungen
US20030225032A1 (en) Pharmaceutical composition
JP2946015B2 (ja) 安定な抗ウィルス点滴用注射剤
JP2770571B2 (ja) 安定化された注射剤および注射剤の安定化法
JPH07109218A (ja) アミド誘導体含有水性液剤
EP0842658B1 (en) Photostable aqueous solution containing benzyl alcohol derivatives
JPWO1994025032A1 (ja) 安定化された注射剤および注射剤の安定化法
JPH05262644A (ja) アミノ酸含有輸液の安定化方法
JPS635091A (ja) 着色防止方法
HK1162975B (en) Stabilised composition comprising at least one adrenergic compound
HK1162975A1 (en) Stabilised composition comprising at least one adrenergic compound